⌕
Bio-Rad Laboratories · BIO · NYSE
Tenet 47 · Mixed
Compare
$358.19−0.57%At closeTenet 47 · Mixed
$358.19−2.07 (−0.57%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD

Bio-Rad Laboratories (BIO) Stock

Bio-Rad Laboratories (BIO) closed at $358.19 on Nov 17, 2026; its Tenet Score is 47 of 100 against 340 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

27 figures withheld by our checks. Each blank figure names its reason.

Key stats

Close
$358.19
Nov 17, 2026
Market cap
$9.7B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
12.7×
fiscal year to Dec 31, 2025 · as of close, Nov 16, 2026
52-week range
236.73 – 396.23
low → high · as of close, Nov 16, 2026
Tenet Score
47/100
Mixed · 340 Healthcare peers

Industry: Health Services

Bio-Rad Laboratories Inc. scores 47/100. Mixed. Growth is the soft spot, trading at 13× earnings versus 340 Healthcare peers.

Tenet Score · vs sector

n=340
47/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
57
Quality
50
Health
52
Growth
28

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueCQualityCHealthCGrowthFMomentumC
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
1.3×
fiscal year to Dec 31, 2025 · as of close, Nov 16, 2026
P/S
3.8×
price to sales, fiscal 2025 · as of close, Nov 16, 2026
ROE
11%
fiscal year to Dec 31, 2025
Operating margin
1.8%
before interest and tax
Net margin
29.4%
fiscal year to Dec 31, 2025
Current ratio
5.62
fiscal year to Dec 31, 2025
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The L…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=340) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 126 US ETFs · top wrappers by weightSee all ETFs holding BIO →

Similar-sized companies in Health Services

The 10 companies in this industry closest in market cap, as of Nov 16, 2026.

What sector and industry is Bio-Rad Laboratories in?

Bio-Rad Laboratories is in the Healthcare sector and the Health Services industry.

What is Bio-Rad Laboratories' Tenet Score?

Bio-Rad Laboratories' Tenet Score is 47 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.